| |
|
Oncologie
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
| CISplatine |
 Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
 |
Cisplatine injectable, BP |
|
Antinéoplasiques
(10:00.00)
|
|
 
|
50mg/50mL (1mg/mL)
|
02355183 |
LAD11102 |
1 |
|
|
| |
100mg/100mL (1mg/mL) |
02355183 |
LAD11103 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemcitabine |
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Gemcitabine pour injection
|
|
Antinéoplasiques
(10:00.00)
|
|
|
200mg (200mg/fiole)
|
02324202 |
LAD10401 |
1 |
|
|
| |
1g (1g/fiole) |
02324210 |
LAD10402 |
1 |
|
|
| |
2g (2g/fiole)
|
02370034 |
LAD10403 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Méthotrexate |
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Méthotrexate injectable, BP |
|
Antinéoplasiques
(10:00.00)
|
|
|
50mg/2mL (25mg/mL)
|
02327236 |
LAD10601 |
10 |
|
|
| |
500mg/2mL (25mg/mL) |
02327236 |
LAD10602 |
1 |
|
|
| |
1g/40mL (25mg/mL) |
02327236 |
LAD10603 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
|
| Pamidronate Disodium OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Pamidronate disodique pour injection
|
|
Agents thérapeutiques divers (92:00)
|
|
|
30mg/10mL (3mg/mL)
|
02249669 |
L0010102 |
1 |
|
|
| |
60mg/10mL (6mg/mL)
|
02249677 |
L0010123 |
1 |
|
|
| |
90mg/10mL (9mg/mL)
|
02249685 |
L0010103 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Topotécan
|
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
|
Chlorhydrate de topotécan pour injection
|
|
Agents antinéoplasiques
(10:00:00)
|
|
|
4mg/fiole
|
02344009 |
LAD10901 |
1 |
|
|
| |
|
|
|
|
|
|
|
